Prolactin-induced expression of vascular endothelial growth factor via Egr-1

Molecular and Cellular Endocrinology

Volumn 232, Issue 1-2, 2005, Pages 9-19

  Goldhar, Anita S ^a   Vonderhaar, Barbara K ^a   Trott, Josephine F ^a,b   Hovey, Russell C ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Angiogenesis; Lymphoma; Mammary gland; Prolactin

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; PROLACTIN; PROLACTIN RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; GC RICH SEQUENCE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 14344261454     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2005.01.005     Document Type: Article

References (68)

1. W.K. Aicher, D. Alexander, C. Haas, S. Kuchen, A. Pagenstecher, S. Gay, H.H. Peter, and H. Eibel Transcription factor early growth response 1 activity up-regulates expression of tissue inhibitor of metalloproteinases 1 in human synovial fibroblasts Arthritis Rheum. 48 2003 348 359
2. R.K. Ball, R.R. Friis, C.A. Schoenenberger, W. Doppler, and B. Groner Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line EMBO J. 7 1988 2089 2095
3. S.K. Banerjee, M.N. Zoubine, T.M. Tran, A.P. Weston, and D.R. Campbell Overexpression of vascular endothelial growth factor 164 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells Int. J. Oncol. 16 2000 253 260
4. C. Bole-Feysot, E. Perret, P. Roustan, B. Bouchard, and P.A. Kelly Analysis of prolactin-modulated gene expression profiles during the Nb2 cell cycle using differential screening techniques Genome Biol. 1 2000 1 15
5. C. Boocock, D. Charnock-Jone, A.M. Sharkey, J. McLaren, P.J. Barker, K.A. Wright, P.R. Twentyman, and S.K. Smith Expression of vascular endothelial growth factor and its receptors Flt and KDR in ovarian carcinoma J. Natl. Cancer Inst. 87 1995 506 516
6. G.M. Church, and W. Gilbert Genomic sequencing Proc. Natl. Acad. Sci. U.S.A. 81 1984 1991 1995
7. K.P. Claffey, K. Abrams, S.-C. Shih, L.F. Brown, A. Mullen, and M. Keough Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis Lab. Investigat. 81 2001 61 75
8. C. Clapp, J.A. Martial, R.C. Guzman, F. Rentier-Delrue, and R. Weiner The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis Endocrinology 133 1993 1292 1299
9. C. Clapp Analysis of the proteolytic cleavage of prolactin by the mammary gland and liver of the rat: characterization of the cleaved and 16K forms Endocrinology 121 1987 2055 2064
10. A.M. Corbacho, G.M. De la Escalera, and C. Clapp Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis J. Endocrinol. 173 2002 219 238
11. K. Cullinan-Bove, and R.D. Koos Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth Endocrinology 133 1993 829 837
12. G. D'Angelo, J.-F. Martini, T. Iiri, W.J. Fantl, J. Martial, and R.I. Weiner 16 K human prolactin inhibits vascular endothelial growth factor-induced activation of ras in capillary endothelial cells Mol. Endocrinol. 13 1999 692 704
13. J.S. De Jong, P.J. Van Diest, P. Van Der Valk, and J.P.A. Baak Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops J. Pathol. 184 1998 44 52
14. V. Djonov, A.-C. Andres, and A. Ziemiecki Vascular remodelling during the normal and malignant life cycle of the mammary gland Microsc. Res. Tech. 52 2001 182 189
15. H.F. Dvorak, J.A. Nagy, D. Feng, L.F. Brown, and A.M. Dvorak Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis Curr. Top. Microbiol. Immunol. 237 1999 97 132
16. A. Erroi, M. Bassetti, A. Spada, and G. Giannattasio Microvasculature of human micro- and macroprolactinomas Neuroendocrinology 43 1986 159 165
17. R.G. Fahmy, and L.M. Khachigian Antisense Egr-1 RNA driven by the CMV promoter is an inhibitor of vascular smooth muscle cell proliferation and regrowth after injury J. Cell. Biochem. 84 2002 575 582
18. N. Ferrara, and T. Davis-Smyth The biology of vascular endothelial growth factor Endocr. Rev. 18 1997 4 25
19. G. Finkenzeller, A. Sparacio, A. Technau, D. Marme, and G. Siemeister Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression Oncogene 24 1997 669 676
20. J. Folkman Angiogenesis and apoptosis Semin. Cancer Biol. 13 2003 159 167
21. A. Gashler, and V.P. Sukhatme Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors Prog. Nucl. Acid Res. Mol. Biol. 50 1995 191 224
22. J. Gille, R.A. Swerlick, and S.W. Caughman Transforming growth factor-a-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation EMBO J. 16 1997 750 759
23. E. Ginsburg, and B.K. Vonderhaar Prolactin synthesis and secretion by human breast cancer cells Cancer Res. 55 1995 2591 2595
24. C.K. Goldman, J. Kim, W.-L. Wong, V. King, T. Brock, and G.Y. Gillespie Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology Mol. Biol. Cell 4 1993 121 133
25. E. Grinstein, F. Jundt, I. Weinert, P. Wernet, and H.-D. Royer Sp1 as G1 cell cycle phase specific transcription factor in epithelial cells Oncogene 21 2002 1485 1492
26. L. Hlatky, C. Tsionou, P. Hahnfeldt, and C.N. Coleman Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vasculasr endothelial growth factor upregulation and protein expression Cancer Res. 54 1994 6083 6086
27. K.A. Houck, D.W. Leung, A.M. Rowland, J. Winer, and N. Ferrara Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms J. Biol. Chem. 267 1992 26031 26037
28. P. Houston, C.J. Campbell, J. Svaren, J. Milbrandt, and M. Braddock The transcriptional corepressor NAB2 blocks Egr-1-mediated growth facor activation and angiogenesis Biochem. Biophys. Res. Commun. 283 2001 480 486
29. R.C. Hovey, A.S. Goldhar, J. Baffi, and B.K. Vonderhaar Transcriptional regulation of vascular endothelial growth factor expression in epithelial and stromal cells during mouse mammary gland development Mol. Endocrinol. 15 2001 819 831
30. N.E. Hynes, D. Taverna, I.M. Harwerth, F. Ciardiello, D.S. Salomon, T. Yamamoto, and B. Groner Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells Mol. Cell. Biol. 10 1990 4027 4034
31. E.A. Jones, J. Conover, and A.J. Symes Identification of a novel gp130-responsive site in the vasoactive intestinal peptide cytokine response element J. Biol. Chem. 275 2000 36013 36020
32. L.M. Khachigian, A.J. Williams, and T. Collins Interplay of Sp1 and Egr-1 in the proximal platelet-derived growth factor A-chain promoter in cultured vascular endothelial cells J. Biol. Chem. 270 1995 27679 27686
33. L.M. Khachigian, V. Lindner, A.J. Williams, and T. Collins Egr-1-induced endothelial gene expression: a common theme in vascular injury Science 271 1996 1427 1431
34. S.K.L. Khurana, A.R. Buckley, and N. Ben-Jonathan Proteolysis of human prolactin: resistance to cathepsin D and formation of a nonangiostatic C-terminal 16 K fragment by thrombin Endocrinology 140 1999 4127 4132
35. J.Y. Ko, Y.L. Ahn, and B.N. Cho Angiogenesis and white blood cell proliferation induced in mice by injection of a prolactin-expressing plasmid into muscle Mol. Cell. 15 2003 262 270
36. J. Komorowski, J. Jankewicz, and H. Stepien Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours Cytobios 101 2000 151 159
37. E. Laughner, P. Taghavi, K. Chiles, P.C. Mahon, and G.L. Semenza HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1a (HIF-1a) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression Mol. Cell. Biol. 21 2001 3995 4004
38. O. Lopez-Ocejo, A. Viloria-Petit, M. Bequet-Romero, D. Mukhopadhyay, J. Rak, and R.S. Kerbel Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner Oncogene 19 2000 4611 4620
39. T. Maeno, T. Tanaka, Y. Sando, T. Suga, Y. Maeno, J. Nakagawa, T. Hosono, M. Sato, H. Akiyama, S. Kishi, R. Nagai, and M. Kurabayashi Stimulation of vascular endothelial growth factor gene transcription by all trans retinoic acid through Sp1 and Sp3 sites in human bronchioloalveolar carcinoma cells Am. J. Resp. Cell Mol. Biol. 26 2002 246 253
40. J.-F. Martini, C. Piot, L.M. Humeau, I. Struman, J.A. Martial, and R.I. Weiner The antiangiogenic factor 16 K Prl induces programmed cell death in endothelial cells by caspase activation Mol. Endocrinol. 14 2000 1536 1540
41. M.B. McAlexander, and L. Yu-Lee Sp1 is required for prolactin activation of the interferon regulatory factor-1 gene Mol. Cell. Endocrinol. 184 2001 135 141
42. D. Mechtcheriakova, A. Wlachos, H. Holzmuller, B.R. Binder, and E. Hofer Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1 Blood 93 1999 3811 3823
43. C.J. Merkle, L.A. Schuler, R.C.J. Schaeffer, J.M. Gribbon, and D.W. Montgomery Structural and functional effect of high prolactin levels on injured endothelial cells Endocrine 13 2000 37 46
44. M.D. Mueller, J.-L. Vigne, A. Minchenko, D.I. Lebovi, D.C. Leitman, and R.N. Taylor Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors a and B Proc. Natl. Acad. Sci. U.S.A. 97 2000 10972 10977
45. J. Nakamura, A. Savinov, Q. Lu, and A. Brodie Estrogen regulates vascular endothelial growth/permeability factor expression in 7,12-dimethylbenz(a) anthracene-induced rat mammary tumors Endocrinology 137 1996 5589 5596
46. G. Niu, K.L. Wright, M. Huang, L. Song, E. Haura, J. Turkson, S. Zhang, T. Wang, D. Sinibaldi, D. Coppola, R. Heller, L.M. Ellis, J. Karras, J. Bromberg, D. Pardoll, R. Jove, and H. Yu Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis Oncogene 21 2002 2000 2008
47. H. Rui, R.A. Kirken, and W.L. Farrar Activation of receptor-associated tyrosine kinase JAK2 by prolactin J. Biol. Chem. 269 1994 5364 5368
48. J.K. Ruohola, E.M. Valve, M.J. Karkkainen, V. Joukov, K. Alitalo, and P.L. Harkonen Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells Mol. Cell. Endocrinol. 149 1999 29 40
49. P.A.E. Scott, J.M. Gleadle, R. Bicknell, and A.L. Harris Role of the hypoxia sensing system, acidity, and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines Int. J. Cancer 1998 706 712
50. D.R. Senger, C.A. Perruzzi, J. Feder, and H.F. Dvorak A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines Cancer Res. 46 1986 5629 5632
51. J.L. Shifren, J.F. Tseng, C.J. Zaloudek, I.P. Ryan, Y.G. Meng, N. Ferrara, R.B. Jaffe, and R.N. Taylor Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis J. Clin. Endocrinol. Metab. 81 1996 3112 3118
52. D.T. Shima, M. Kuroki, U. Deutsch, N.-S. Ng, A.P. Adamis, and P.A. D'Amore The mouse gene for vascular endothelial growth factor J. Biol. Chem. 271 1996 3877 3883
53. R.P. Shiu, H.P. Elsholtz, T. Tanaka, H.G. Friesen, P.W. Gout, C.T. Beer, and R.L. Noble Receptor-mediated mitogenic action of prolactin in a rat lymphoma cell line Endocrinology 113 1983 159 165
54. C. Skerka, E.L. Decker, and P.F. Zipfel A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 J. Biol. Chem. 270 1995 22500 22506
55. S. Srivastava, M.N. Weitzmann, R.B. Kimble, M. Rizzo, M. Zahner, J. Milbrandt, F.P. Ross, and R. Pacifici Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1 J. Clin. Invest. 102 1998 1850 1859
56. M. Stoner, M. Wormke, B. Saville, I. Samudio, C. Qin, M. Abdelrahim, and S. Safe Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins Oncogene 23 2004 1052 1063
57. I. Struman, F. Bentzien, H. Lee, V. Mainfroid, G. D'Angelo, V. Goffin, R.I. Weiner, and J.A. Martial Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis Proc. Natl. Acad. Sci. U.S.A. 96 1999 1246 1251
58. V.P. Sukhatme, S. Kartha, F.G. Toback, R. Taub, R.G. Hoover, and C.H. Tsai-Morris A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens Oncogene Res. 1 1987 343 355
59. I.L. Szabo, R. Pai, B. Soreghan, M.K. Jones, D. Baatar, K. Hirofumi, and A.S. Tarnawski NSAIDs inhibit the activation of egr-1 gene in microvascular endothelial cells. A key to inhibition of angiogenesis? J. Physiol. 95 2001 379 383
60. C. Tonello, A. Giordano, V. Cozzi, S. Cinti, M.J. Stock, M.O. Carruba, and E. Nisoli Role of sympathetic activity in controlling the expression of vascular endothelial growth factor in brown fat cells of lean and genetically obese rats FEBS Lett. 442 1999 167 172
61. C.K.L. Too Induction of Sp1 activity by prolactin and interleukin-2 in Nb2 T-cells: differential association of Sp1-DNA complexes with Stats Mol. Cell. Endocrinol. 129 1997 7 16
62. J.F. Trott, R.C. Hovey, S. Koduri, and B.K. Vonderhaar Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein J. Mol. Endocrinol. 30 2003 31 47
63. Vonderhaar, B.K., 1999. Prolactin and breast cancer. In: Women and Cancer, pp. 7-20.
64. N. Weidner, J.P. Semple, W.R. Welch, and J. Folkman Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma New Engl. J. Med. 324 1991 1 8
65. J. Wu, J. Richer, K.B. Horwitz, and S.M. Hyder Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B Cancer Res. 64 2004 2238 2244
66. B. Xie, N.N. Tam, S.W. Tsao, and Y.C. Wong Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat Br. J. Cancer 81 1999 1335 1343
67. S.-F. Yan, T. Fujita, J. Lu, K. Okada, Y.S. Zou, N. Mackman, D.J. Pinsky, and D.M. Stern Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress Nat. Med. 6 2000 1355 1361
68. M. Yang, H. Nomura, Y. Hu, S. Kaneko, H. Kaneko, M. Tanaka, and K. Nakashima Prolactin-induced expression of TATA-less cyclin D3 gene is mediated by Sp1 and Ap2 Biochem. Mol. Biol. Int. 44 1998 51 58